Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors", that control how those genes are read.

A ‘SUPER VACCINE’ could stop three types of cancer in their tracks – shrinking tumours and preventing spread. US researchers ...

As cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional ...

Black men are living shorter than anyone else, besides Native American and Alaskan men, according to the 2025 “Real Face of ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

A year after the FDA approved the use of AngioDynamics' NanoKnife device for prostate cancer treatment, the magazine lists it ...

When Erin Bacon, 33, called to cancel her double mastectomy, doctors told her she was going to die. Now she says a new ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Scientists have found a key weakness in prostate cancer cells. Two enzymes, PDIA1 and PDIA5, help cancer cells survive and ...

Consultant Urologist at the Urology and Nephrology Center of Excellence at the Korle Bu Teaching Hospital (KBTH), Dr Isaac ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...